HyunIl Kim - ISU Abxis Exec

All Insiders Korea . 
Stock . ISU Abxis Co . Stakeholders . Insider . HyunIl Kim
086890 Stock  KRW 4,465  10.00  0.22%   

Insider

HyunIl Kim is Exec of ISU Abxis Co
Phone82 3 1696 4700
Webhttps://www.abxis.com

ISU Abxis Management Efficiency

The company has return on total asset (ROA) of (0.0463) % which means that it has lost $0.0463 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.4857 %, meaning that it generated $0.4857 on every $100 dollars invested by stockholders. ISU Abxis' management efficiency ratios could be used to measure how well ISU Abxis manages its routine affairs as well as how well it operates its assets and liabilities.
ISU Abxis Co has accumulated 24.02 B in total debt with debt to equity ratio (D/E) of 2.6, implying the company greatly relies on financing operations through barrowing. ISU Abxis has a current ratio of 6.95, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist ISU Abxis until it has trouble settling it off, either with new capital or with free cash flow. So, ISU Abxis' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like ISU Abxis sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for ISU to invest in growth at high rates of return. When we think about ISU Abxis' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Seung LeeALTEOGEN
N/A
Jong WonABL Bio
N/A
DukYong KimKmw Inc
66
HyukJin GwonCelltrion Pharm
N/A
YunHyun KangCelltrion Pharm
N/A
Jaecheon LeeABL Bio
N/A
SangSuk KimCelltrion Pharm
N/A
SangMee LeeALTEOGEN
N/A
ChangJin KimCelltrion Pharm
N/A
HyeShin ChungALTEOGEN
N/A
Kyuwan KimALTEOGEN
N/A
Jungsu SeoCelltrion Pharm
N/A
Wang LeeCelltrion Pharm
63
Sang KangALTEOGEN
N/A
Yeong YooCelltrion Pharm
53
Vivek MBAALTEOGEN
N/A
SoonJae ParkALTEOGEN
N/A
You WeonKyooABL Bio
N/A
KwanDeok JangKmw Inc
65
EunSuk ChoiCelltrion Pharm
N/A
DongHo WooCelltrion Pharm
N/A
ISU Abxis Co., Ltd., a biopharmaceutical company, develops and markets products for the treatment of cancer and rare diseases worldwide. ISU Abxis Co., Ltd. is headquartered in Seongnam, South Korea. ISU ABXIS is traded on Korean Securities Dealers Automated Quotations in South Korea. ISU Abxis Co (086890) is traded on KOSDAQ in Korea and employs 16 people.

Management Performance

Return On Equity0.49
Return On Asset-0.0463

ISU Abxis Leadership Team

Elected by the shareholders, the ISU Abxis' board of directors comprises two types of representatives: ISU Abxis inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ISU. The board's role is to monitor ISU Abxis' management team and ensure that shareholders' interests are well served. ISU Abxis' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ISU Abxis' outside directors are responsible for providing unbiased perspectives on the board's policies.
ChangHoon Choi, Exec
SangHo Park, Chief Officer
JaeHeung Lee, Exec
HyunIl Kim, Exec
JinChul Shin, Exec
JoonYoung Park, Exec
SungHo Choi, Exec
HeungRok Park, Exec
YoungSoo Sohn, Exec
Seungho Kim, Exec

ISU Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ISU Abxis a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.49
Return On Asset-0.0463
Profit Margin(0.57) %
Operating Margin(0.30) %
Current Valuation365.33 B
Shares Outstanding26.63 M
Shares Owned By Insiders33.85 %
Shares Owned By Institutions0.19 %
Price To Sales5.25 X
Revenue28.02 B

Pair Trading with ISU Abxis

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ISU Abxis position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ISU Abxis will appreciate offsetting losses from the drop in the long position's value.

Moving together with ISU Stock

  0.72207940 Samsung BiologicsPairCorr
  0.72326030 Sk BiopharmaceuticalsPairCorr
  0.73298380 ABL BioPairCorr
  0.96144510 Green Cross LabPairCorr

Moving against ISU Stock

  0.91035420 NaverPairCorr
  0.83032640 LG UplusPairCorr
  0.65003535 Hanwha InvestmentSecuriPairCorr
  0.63039240 Gyeongnam SteelPairCorr
  0.51011200 HMM CoPairCorr
The ability to find closely correlated positions to ISU Abxis could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ISU Abxis when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ISU Abxis - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ISU Abxis Co to buy it.
The correlation of ISU Abxis is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ISU Abxis moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ISU Abxis moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ISU Abxis can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in ISU Stock

ISU Abxis financial ratios help investors to determine whether ISU Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ISU with respect to the benefits of owning ISU Abxis security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY